Nifedipine (Adalat CR, BAY A1040) High Dose PK/PD Study

PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
Hypertension
Interventions
DRUG

Nifedipine (Adalat CR, BAYA1040) 80mg OD

Nifedipine (Adalat CR, BAYA1040) 80 milligram (mg) once daily (OD) in the morning

DRUG

Nifedipine (Adalat CR, BAYA1040) 40mg BID

Nifedipine (Adalat CR, BAYA1040) 40 milligram (mg) twice daily (BID). 40 mg in the morning and 40 mg in the evening

DRUG

Nifedipine (Adalat CR, BAYA1040) 40mg OD

Nifedipine (Adalat CR, BAYA1040) 40 milligram (mg) once daily (OD) in the morning

Trial Locations (3)

982-0032

Sendai

565-0853

Suita

343-0827

Koshigaya

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bayer

INDUSTRY